Estrace (estradiol) / AbbVie  >>  Phase 1
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Estrace (estradiol) / AbbVie
NCT00799708: A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)

Completed
1
27
US
Comparator: placebo, Comparator: Estrace, Estrace
Merck Sharp & Dohme LLC
Postmenopause
10/08
10/08
NCT00820664: A Clinical Study to Evaluate the Effects of Estrogen in Healthy Postmenopausal Women

Completed
1
29
US
Comparator: Estrace 0.5 mg, Estrace, Comparator: Estrace 2 mg, Comparator: Placebo
Merck Sharp & Dohme LLC
Postmenopausal Symptoms
05/09
05/09
NCT02673606: Impact of Estrogen on Fear Extinction R61

Completed
1
136
US
Estradiol 2Mg Tablet, Estrace® Tablets, Estradiol 4Mg Tablet, Placebo Pills
NYU Langone Health
Fear, Fear; Examination, Phobic
04/19
04/19
NCT03371654: Estrogen and Fear (PTSD)

Recruiting
1
80
US
Estradiol, Estrace, Placebo
NYU Langone Health
Stress Disorders, Post-Traumatic, Healthy
11/22
11/22
NCT05458375: Vaginal Estradiol Use in Pessary Care

Terminated
1
11
US
Estradiol vaginal cream, Estrace, National Drug Code 0430-3754
University of South Florida
Pelvic Organ Prolapse, Urinary Incontinence, Pessary Ulcer of Vagina, Vaginal Atrophy
04/23
04/23
PHOEBE, NCT05900895: Estradiol Plus Olaparib for Breast Cancer

Recruiting
1
6
US
Olaparib, Lynparza, 17b-estradiol, Estrace
Mary D Chamberlin, Dartmouth-Hitchcock Medical Center
Metastatic Breast Cancer
12/27
12/28

Download Options